The U.S. Food and Drug Administration has endorsed the University of Michigan 's participation in a clinical trial designed to assess the effectiveness of stem cells in the treatment of patients with what is known commonly as "Lou Gehrig's disease," but which is formally named amyotrophic lateral sclerosis, or ALS .
http://www.examiner.com/article/fda-endorses-michigan-s-participation-als-stem-cell-trial
http://www.examiner.com/article/fda-endorses-michigan-s-participation-als-stem-cell-trial
No comments:
Post a Comment